Live Breaking News & Updates on Surging amid less severe

Stay informed with the latest breaking news from Surging amid less severe on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Surging amid less severe and stay connected to the pulse of your community

What We're Reading: Phase 3 Gene Therapy Trial; COVID Infection Surge; Patients Maintain Anti-Obesity Drug Weight Loss

Sarepta Therapeutics has started screening participants for a Phase 3 clinical trial to test its gene therapy candidate SRP-9003 in children with limb-girdle muscular dystrophy type 2E; wastewater testing points to a new COVID-19 infection wave fueled by the JN.1 variant; most patients on anti-obesity medications kept at least some weight off up to a year after they stopped taking them.

United-states , Americans , Eduardo-azziz-baumgartner , Gene-therapy , Children-with , Muscular-dystrophy , Surging-amid-less-severe , What-we-x27-re-reading , Covid-19-infection , Jn-1-variant , Anti-obesity-medication